![](/wp-content/uploads/2020/10/Merck-Lilly-Pfizer-Novartis-Earnings.png)
$599
Lilly, Novartis, Pfizer, and Merck Q3 ’20 Earnings Updates
Lilly, Novartis, Pfizer, and Merck each hosted their respective Q3 ’20 earnings calls and provided updates across a variety of topics. Importantly, it was disclosed that FDA has requested an advisory committee meeting to discuss Novartis’s Entresto PARAGON-HF submission. Below, FENIX provides highlights and insights from the respective earnings calls.